This post was originally published on Medscape
You will shortly be re-directed to the publisher's website
Patients with pulmonary arterial hypertension and cardiovascular comorbidities may benefit from the use of inhaled or oral treprostinil as an add-on to oral monotherapy, a post hoc analysis suggested.
Medscape Medical News